Trial Operations Excellence & Innovation Lead

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.

PURPOSE OF THE FUNCTION:The Director, Trial Operations Excellence & Innovation Lead is responsible for shaping and executing the strategic transformation agenda for Clinical Trial Operations and ensuring organizational readiness in line with argenx vision.

The role provides strategic leadership across Trial Operations and partner roles to identify, prioritize, and operationalize future capabilities, including imaging, Digital Health Technologies (DHT), decentralized trial capabilities, automation, AI-enabled operational processes, and emerging trial execution models.

As a key member of the Trial Operations leadership team, this individual ensures that argenx remains at the forefront of operational innovation while enabling sustainable portfolio growth, inspection readiness, and exceptional trial execution.

REPORTING LINE:The Trial Operations Excellence & Future Capabilities Lead reports to the Global Head Trial Operations.

Direct reports include: Lead Operational Excellence; eCOA Center of Excellence personnel; Future capability project leads as assigned; X-indication COL

ROLES AND RESPONSIBILITIES (non-exhaustive list): Strategic Leadership & Future Readiness

• Define and execute the Trial Operations strategic transformation roadmap aligned with argenx vision.

• Identify future capability requirements needed to support portfolio growth, increasingly complex trial designs, and evolving regulatory expectations.

• Serve as a thought leader for innovative trial operations approaches and emerging technologies, including but not limited to AI technology.

• Translate strategic priorities into executable programs with measurable business outcomes.

• Partner with Trial Operations leadership to establish long-term operational capability plans.

• Establish a continuous improvement culture throughout Trial Operations.

• Drive standardization, simplification, and optimization of operational processes.

• Sponsor and oversee major process improvement initiatives.

Center of Excellence Leadership

• Act as a thought partner to the eCOA Center of Excellence Lead

• Establish and lead Centers of Excellence for emerging operational capabilities including imaging, Digital Health Technologies (DHT); Wearables and remote monitoring solutions; Hybrid and decentralized trial methodologies; AI-enabled operational tools

• Develop implementation frameworks enabling scalable adoption across the portfolio.

Cross-Asset Strategic Initiatives

• Oversee x-asset and x-indication strategic initiatives that require coordinated execution across multiple development programs.

• Partner with Asset Teams, CODLs, FCODLs, and Program Leadership to identify opportunities for harmonization and standardization.

• Drive portfolio-wide solutions that reduce operational complexity and accelerate development timelines.

• Serve as the primary Trial Operations representative for enterprise-wide operational transformation initiatives and act as the primary point of contact for (CRO) partners to drive innovation & digital transformation.

• E...